These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patients. Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Barocci S, Cantaluppi A, Salit M. ASAIO Trans; 1990 Feb; 36(3):M467-9. PubMed ID: 2174688 [Abstract] [Full Text] [Related]
8. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Moutabarrik A, Nakanishi I, Namiki M, Tsubakihara Y. Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878 [Abstract] [Full Text] [Related]
9. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S. Adv Perit Dial; 1997 Apr; 13():7-12. PubMed ID: 9360642 [Abstract] [Full Text] [Related]
10. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785 [Abstract] [Full Text] [Related]
17. Formation of leukotriene B4, 20-hydroxy leukotriene B4 and other arachidonic acid metabolites by macrophages during peritonitis in patients with continuous ambulatory peritoneal dialysis. Zijlstra FJ, van den Broek AM, Vincent JE, Diderich PP, op de Hoek-Fes AM, Claeys M. Prostaglandins Leukot Med; 1987 May; 27(2-3):151-60. PubMed ID: 3039532 [Abstract] [Full Text] [Related]